Jen L, PhD
LightNews LightNews
banner
drjkyl.bsky.social
Jen L, PhD
@drjkyl.bsky.social
2.4K followers 14K following 270 posts
Executive Editor/Team Leader Open Access Science Journals Sage Publishing
Opinions = mine

http://linkedin.com/in/jlovick-editor

#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare #technology
Posts Replies Media Videos
Pinned
drjkyl.bsky.social
Jen L, PhD @drjkyl.bsky.social · Feb 21
Introduction - PhD working in academic publishing, lead a team of amazing Managing Editors that support @sagepub.com @journals.sagepub.com 's Open Access Biomedical Journals. I'll be sharing recent articles from our journals that I find interesting. Happy to connect with researchers! 📖🔬🧪💊⚕️
Reposted by Jen L, PhD
celltransplant1992.bsky.social
Impact of posaconazole tablets for secondary prophylaxis on drug interactions in haploidentical allogeneic #stem #cell #transplantation: A single-arm, open-label, prospective study
doi.org/10.1177/0963...
@journals.sagepub.com
November 21, 2025 at 7:28 AM
Reposted by Jen L, PhD
celltransplant1992.bsky.social
Effects of bivalirudin on instant blood-mediated #inflammatory reaction after intraportal #islet #transplantation
doi.org/10.1177/0963...
#diabete
@journals.sagepub.com
November 21, 2025 at 7:36 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
New #SystematicReview from our Special Collection on Neuromyelitis Optica Spectrum Disorders:
Which environmental risk factors influence the onset of the disease?
Find out more here: journals.sagepub.com/doi/full/10....
Environmental risk factors of neuromyelitis optica spectrum disorder: a systematic review - Mahsa Mohammadi Lapevandani, Elham Bazmi, Shima Jahani, Nasrin Asgari, Mohammad Ali Sahraian, 2025
Background: Neuromyelitis optica spectrum disorder (NMOSD) may be triggered by environmental risk factors. Objectives: We aimed to explore and integrate the re...
journals.sagepub.com
November 21, 2025 at 9:49 AM
Reposted by Jen L, PhD
tamedoncol.bsky.social
Network meta-analysis of 11 RCTs: EV+pembrolizumab ranks highest for OS, PFS & ORR in la/mUC. Safety acceptable vs chemo. Details buff.ly/Wsqr2nQ
#CancerResearch #BladderCancer
November 23, 2025 at 8:15 AM
Reposted by Jen L, PhD
tainfdis.bsky.social
Data from 89 patients suggest that follow-up FDG-PET/CT can guide decisions in focal infections but is most informative when bacteremia is gram-positive or clinical status deteriorates. Findings support targeted rather than routine use. 🔍🦠📊 journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
November 23, 2025 at 8:52 PM
Reposted by Jen L, PhD
linglingtian.bsky.social
📢 Article in collection “State of the art and latest progress in the care of breast cancer in young women”:
Fertility preservation in young patients with breast cancer: insights from the Gemme Dormienti network
🔗 Read the article + explore the full collection: buff.ly/43hbqmf
November 24, 2025 at 8:15 AM
Reposted by Jen L, PhD
naturalproductcomm.bsky.social
Top Read Papers on Natural Product Communications - November 2025

💡 1. Menthol: A Comprehensive Review of Its Pharmacological Properties and Therapeutic Applications

Prof. K. Husnu Can Baser, Dr. Emine Erdag and Dr. Ismail Celil Haskologlu

journals.sagepub.com/doi/full/10....
November 24, 2025 at 10:04 AM
Reposted by Jen L, PhD
naturalproductcomm.bsky.social
Top Read Papers on Natural Product Communications - November 2025

💡 2. A Review of Phytocompounds of “Leaf of Life” Medicinal Plant (Kalanchoe pinnata (Lam.) Pers)

journals.sagepub.com/doi/10.1177/...
November 24, 2025 at 10:17 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
New from our Special Collection on
Innovative treatments for migraine: a new era

Here, Katsuki and colleagues present trends in real-world use of #lasmiditan for migraine in Japan, using nationwide health insurance claims data.
journals.sagepub.com/doi/full/10....
November 24, 2025 at 10:35 AM
Reposted by Jen L, PhD
tamedoncol.bsky.social
Adding immune checkpoint inhibitors to neoadjuvant chemo improves pCR in advanced gastric cancer. Real-world evidence from a retrospective cohort study. Read more: buff.ly/xzkJ8cL #GastricCancer #Oncology
November 25, 2025 at 8:15 AM
Reposted by Jen L, PhD
naturalproductcomm.bsky.social
Top Read Papers on Natural Product Communications - November 2025

💡3. LC-MS Profiling and Anti-Inflammatory Activity of Saurauia fasciculata Bark: Network Pharmacology, Molecular Docking, MD Simulation, and in-Vitro Validation

journals.sagepub.com/doi/10.1177/...
November 25, 2025 at 10:10 AM
Reposted by Jen L, PhD
tainfdis.bsky.social
AI-driven models are showing clear promise in improving HIV/TB detection and management in Nigeria, where immunosuppression drives disproportionate TB risk. Strengthening technical capacity will be essential for translating this potential into practice.
journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
November 25, 2025 at 2:17 PM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
Could brain natriuretic peptide and echocardiographic parameters serve as biomarkers for predicting new atrial fibrillation after acute ischemic stroke?

Stefano Forlivesi and colleagues investigate:
journals.sagepub.com/doi/full/10....
#Stroke #AFib
November 25, 2025 at 3:25 PM
drjkyl.bsky.social
Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent Clostridioides difficile infection from five prospective clinical trials: an update
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#microbiome #gastroenterology
November 21, 2025 at 7:16 PM
drjkyl.bsky.social
Neoadjuvant vs. Adjuvant Chemotherapy for Luminal B Breast Cancer: A Systematic Review and Meta-Analysis – Where is the Evidence?
@cancer-control.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancertreatment #oncology #medicine #openaccess
November 21, 2025 at 7:15 PM
drjkyl.bsky.social
Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#gastroenterology #healthcare #medicine #openaccess
November 21, 2025 at 7:13 PM
drjkyl.bsky.social
Impact of a multistep urinary tract infection-focused disease state stewardship initiative on the treatment of asymptomatic urinary presentations: a retrospective cohort study
@tainfdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...

#infectiousdisease #healthcare #medicine
November 21, 2025 at 7:11 PM
drjkyl.bsky.social
Effectiveness of Chemotherapy Plus Immunotherapy and Molecular Alterations in Advanced Biliary Tract Cancer: Real-World Evidence From a Single-Center Australian Cohort
@cancer-control.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#carcinoma #biomarkers #oncology #prognosis
November 21, 2025 at 7:09 PM
drjkyl.bsky.social
Comparative analysis of streptozocin-based regimen and capecitabine–temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancer #oncology #chemotherapy
November 21, 2025 at 7:06 PM
Reposted by Jen L, PhD
tainfdis.bsky.social
Antibiotics disrupt gut/airway microbiomes across ages 🦠, amplifying both targeted and background resistance genes 🧬. Recovery remains especially poor in children 👶
journals.sagepub.com/doi/full/10....
November 15, 2025 at 2:41 PM
Reposted by Jen L, PhD
tamedoncol.bsky.social
🔬 CDK4/6 inhibitors have transformed HR+ MBC care - but resistance is a growing challenge.

This review explores the molecular drivers and emerging strategies to counteract them. Full article 👉 buff.ly/1YracNB #CancerResearch #Oncology
November 17, 2025 at 8:15 AM
Reposted by Jen L, PhD
linglingtian.bsky.social
This review explores how gut microbes may drive tumor initiation, progression, and therapy response - and how microbiome-targeted strategies could transform outcomes in one of the deadliest cancers. Read here 👉 buff.ly/dWH87rO #PancreaticCancer #Microbiome #Oncology #CancerResearch
November 17, 2025 at 8:15 AM
Reposted by Jen L, PhD
tamedoncol.bsky.social
We’re proud to see our Associate Editor, Prof. Nadia Harbeck, contributing to the upcoming #ESMOYOC YO4YO HowTo session on career crossroads in oncology. Don’t miss it! 📅 25 Nov, 15:00 CET. #YoungOncologists
myesmo.bsky.social ESMO - European Society for Medical Oncology @myesmo.bsky.social · 9d
Get ready for the next YO4YO HowTo Virtual session with Ana Tecic Vuger, Nadia Harbeck and Kevin Punie MD #YoungOncologists #ESMOYOC
📌 Career Crossroads in #Oncology: Clinical, #research, and #leadership journeys
📅 25 November 2025
🕒 15:00–16:00 CET
🔗 https://ow.ly/R7MJ50XpRy1
November 17, 2025 at 8:44 AM
Reposted by Jen L, PhD
linglingtian.bsky.social
Thrilled to see our Associate Editor, Nadia Harbeck, share her expertise at the upcoming #ESMOYOC YO4YO HowTo session. Career crossroads in oncology is such a timely topic - looking forward to the discussion!
myesmo.bsky.social ESMO - European Society for Medical Oncology @myesmo.bsky.social · 9d
Get ready for the next YO4YO HowTo Virtual session with Ana Tecic Vuger, Nadia Harbeck and Kevin Punie MD #YoungOncologists #ESMOYOC
📌 Career Crossroads in #Oncology: Clinical, #research, and #leadership journeys
📅 25 November 2025
🕒 15:00–16:00 CET
🔗 https://ow.ly/R7MJ50XpRy1
November 17, 2025 at 8:45 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
New article in our Special Collection: New Frontiers in Acute Reperfusion Therapies for Acute Ischemic Stroke

This Review synthesizes evidence for the effectiveness of "Drip & Ship" model in acute #stroke care: 🚑
journals.sagepub.com/doi/full/10....
November 18, 2025 at 9:53 AM